Development of method to evaluate anti-oxidative capability of Kampo in chronic kidney disease
Not Applicable
- Conditions
- Chronic kidney disease
- Registration Number
- JPRN-UMIN000000850
- Lead Sponsor
- Keio University School of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
Not provided
Exclusion Criteria
patients taking other Kampo medication than Hochu-ekki-tou. patients who have experienced adverse effects of Kampo medication.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method to evaluate the ability of Kampo to reduce oxidative stress with the use of oxidative/redox tiol compounds or monoclonal antibodies.
- Secondary Outcome Measures
Name Time Method